HealthEquity, Inc (HQY) PT Raised to $77 at Chardan Capital Markets

Chardan Capital Markets raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $77.00 (from $62.00) while maintaining a Buy rating.

Analyst Steven Wardell comments "We liked the strong demand we are seeing from the marketplace and strong execution from Management. We raise our PT at $77 based on earnings growth through FY21E and multiple expansion that will bring HQY's valuation to a slight premium over its peers."

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Southwest (LUV) PT Raised to $61 at UBS Ahead of Q2 Print
• Delta Air Lines (DAL) PT Raised to $107 at UBS Ahead of Q2 Results